Head to Head Analysis: Modular Medical (NASDAQ:MODD) versus Nyxoah (NASDAQ:NYXH)

Modular Medical (NASDAQ:MODD) and Nyxoah (NASDAQ:NYXH) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, profitability, valuation, earnings, risk and institutional ownership.

Volatility and Risk

Modular Medical has a beta of 0.5, indicating that its stock price is 50% less volatile than the S&P 500. Comparatively, Nyxoah has a beta of 1.58, indicating that its stock price is 58% more volatile than the S&P 500.

Profitability

This table compares Modular Medical and Nyxoah’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Modular Medical	N/A	-235.93%	-180.37%
Nyxoah	-993.28%	-38.58%	-31.24%

Earnings and Valuation

This table compares Modular Medical and Nyxoah’s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Modular Medical	N/A	N/A	-$13.88 million	($0.97)	-1.66
Nyxoah	$4.70 million	N/A	-$46.77 million	($1.68)	-5.81

Modular Medical has higher earnings, but lower revenue than Nyxoah. Nyxoah is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

27.5% of Modular Medical shares are held by institutional investors. 32.3% of Modular Medical shares are held by company insiders. Comparatively, 17.1% of Nyxoah shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Modular Medical and Nyxoah, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Modular Medical	0	0	2	0	3.00
Nyxoah	0	1	5	0	2.83

Modular Medical currently has a consensus target price of $4.25, indicating a potential upside of 163.98%. Nyxoah has a consensus target price of $20.60, indicating a potential upside of 111.07%. Given Modular Medical’s stronger consensus rating and higher possible upside, research analysts clearly believe Modular Medical is more favorable than Nyxoah.

Summary

Modular Medical beats Nyxoah on 8 of the 13 factors compared between the two stocks.

About Modular Medical

Modular Medical, Inc. operates as a development stage medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for diabetes. The company was founded in 1998 and is headquartered in San Diego, California.

About Nyxoah

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.